Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 9 January 2009, doi:10.1136/bmj.b41
Cite this as: BMJ 2009;338:b41
| The first 150 words of the full text of this article appear below. |
Firth and colleagues analysis of all the deaths on Mount Everest during 1921-2006 did not address some important points.1
Did more climbers die on their first attempt than on subsequent attempts? What drugs were they taking? Some climbers might be taking dexamethasone.2 The summit bid starts at midnight, which may be a confounding factor for death while climbing. Similarly, crowded climbing and delaying the summit bid should also be considered.
How was ataxia assessed? Climbers are using crampons, are roped, and have oxygen cylinders and masks in addition to gloves and clothing. Ataxia cannot be diagnosed unless Rombergs test or the sharpened Romberg test is done.
Most importantly, the authors did not consider high altitude deterioration3 as an important factor in causing death at such extreme altitudes with the longer time of exposure. Instead, they speculate that headache, nausea, and vomiting are not heralds of high altitude cerebral oedema at
Matiram Pun, junior doctor1
1 Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal
matiram@gmail.com
Read all Rapid Responses